Krajina: Izrael
Jazyk: hebrejčina
Zdroj: Ministry of Health
CLOZAPINE 25 MG
NOVARTIS PHARMA SERVICES AG
N05AH02
TABLETS
PER OS
NOVARTIS PHARMACEUTICALS LTD, UK
CLOZAPINE
Treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. Suicidal behavior refers to actions by a patient that put him/herself at risk for death.
2012-10-01